About Our Company
Peptimmune is a clinical stage biotechnology company developing peptide and peptide-copolymer therapeutics for the treatment of CNS and Autoimmune disorders. These therapies target MHC Class II molecules and modulating immune responses. Founded in 2002 and located in Cambridge, MA USA, the Company is led by an experienced management team and exploits its proprietary DEEP™ Technology to design peptides and peptide mixtures.
Meet Our Team
Emily Sudhyadhom
Principal Research Associate
Emily joined Peptimmune as a senior research associate in 2008 with over eight years of experience in the pharmaceutical industry. Prior to Peptimmune, Emily was at Alkermes and Watson Pharmaceuticals where she held senior…
